Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes

Area of Science:

• Hematology
• Immunology
• Cell Biology

Background:

• Childhood acute lymphoblastic leukemia (ALL) relapse presents unique challenges in treatment and research.
• Establishing reliable cell lines is crucial for understanding leukemia biology and developing targeted therapies.

Purpose of the Study:

• To establish and characterize novel leukemic cell lines from pediatric ALL patients in relapse.
• To investigate the immunophenotypic and genetic features of these cell lines for insights into leukemia development.

Main Methods:

• Bone marrow cells from children with ALL in relapse were used to establish cell lines (697 and 207).
• Immunophenotyping was performed using common-ALL antigen (CALLA), HLA-DR, immunoglobulin heavy and light chains, terminal deoxynucleotidyl transferase, myeloid-macrophage (MMA), and natural killer cell (HNK-1) markers.
• Monoclonal antibodies were used to detect T-cell antigens (T-1, T-6, Leu-1).
• Epstein-Barr virus (EBV) status was determined.
• Cytogenetic analysis, including marker chromosome identification (translocation 7;19), was conducted.

Main Results:

• Cell lines 697 and 207 were positive for CALLA, HLA-DR, and cytoplasmic/surface IgM, but negative for other immunoglobulins.
• Elevated terminal deoxynucleotidyl transferase levels and expression of MMA and HNK-1 antigens were observed.
• Line 207 showed a minority of cells expressing T-cell antigens.
• Line 697 was EBV-positive; line 207 was EBV-negative.
• Line 697 carried a 7;19 translocation marker chromosome present in the patient's cells.
• Both lines demonstrated phenotypic characteristics of cells arrested between pre-B and B cell developmental stages.

Conclusions:

• The established cell lines (697 and 207) are valuable tools for studying pediatric ALL relapse.
• These cell lines exhibit a unique immunophenotype, expressing B-cell lineage markers alongside myeloid and NK cell antigens.
• The findings suggest a potential developmental arrest in early B-cell differentiation and highlight the utility of these lines for leukemia research.